{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:09:01Z","timestamp":1782310141724,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10067-022-06201-3","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:03:01Z","timestamp":1652248981000},"page":"2581-2588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know?"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-595X","authenticated-orcid":false,"given":"Abhimanyu","family":"Amarnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-0916","authenticated-orcid":false,"given":"Suchi","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-2257","authenticated-orcid":false,"given":"Richard S.","family":"Panush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"6201_CR1","doi-asserted-by":"publisher","first-page":"e001558","DOI":"10.1136\/rmdopen-2020-001558","volume":"7","author":"M Ashrafi","year":"2021","unstructured":"Ashrafi M, Kuhn KA, Weisman MH (2021) The arthritis connection to inflammatory bowel disease (IBD): why has it taken so long to understand it? RMD Open 7:e001558","journal-title":"RMD Open"},{"key":"6201_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT (2021) Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology 161:1118\u201332","journal-title":"Gastroenterology"},{"key":"6201_CR3","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","volume":"25","author":"GE Fragoulis","year":"2019","unstructured":"Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T (2019) Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment. World J Gastroenterol 25:2162","journal-title":"World J Gastroenterol"},{"key":"6201_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12178-011-9085-8","volume":"4","author":"SL Arvikar","year":"2011","unstructured":"Arvikar SL, Fisher MC (2011) Inflammatory bowel disease associated. Arthropathy. Curr Rev Musculoskelet Med 4:123\u201331","journal-title":"Curr Rev Musculoskelet Med"},{"key":"6201_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/art.1780030109","volume":"3","author":"N Zvaifler","year":"1960","unstructured":"Zvaifler N, Martel W (1960) Spondylitis in chronic ulcerative colitis. Arthritis Rheum 3:76\u201387","journal-title":"Arthritis Rheum"},{"key":"6201_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"T Orchard","year":"1998","unstructured":"Orchard T, Wordsworth B, Jewell D (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387\u201391","journal-title":"Gut"},{"key":"6201_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/rheumatology\/XXVII.suppl_2.95","volume":"27","author":"H Mielants","year":"1988","unstructured":"Mielants H, Veys E, Cuvelier C, De Vos M (1988) Ileocolonoscopic findings in seronegative spondylarthropathies. Rheumatology 27:95\u2013105","journal-title":"Rheumatology"},{"key":"6201_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","volume":"23","author":"FT Veloso","year":"1996","unstructured":"Veloso FT, Carvalho J, Magro F (1996) Immune-related systemic manifestations of inflammatory bowel disease: a prospective study of 792 patients. J Clin Gastroenterol 23:29\u201334","journal-title":"J Clin Gastroenterol"},{"key":"6201_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/ibd\/izaa198","volume":"27","author":"I Levine","year":"2021","unstructured":"Levine I, Malik F, Castillo G et al (2021) Prevalence, predictors, and disease activity of sacroiliitis among patients with Crohn\u2019s disease. Inflamm Bowel Dis 27:809\u201315","journal-title":"Inflamm Bowel Dis"},{"key":"6201_CR10","first-page":"631","volume":"11","author":"MC Karreman","year":"2017","unstructured":"Karreman MC, Luime JJ, Hazes JM, Weel AE (2017) The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohn\u2019s Colitis 11:631\u201342","journal-title":"J Crohn's Colitis"},{"key":"6201_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3899\/jrheum.181326","volume":"47","author":"D Wendling","year":"2020","unstructured":"Wendling D, Guillot X, Prati C et al (2020) Effect of gut involvement in patients with high probability of early spondyloarthritis: data from the DESIR cohort. J Rheumatol 47:349\u201353","journal-title":"J Rheumatol"},{"key":"6201_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/ard.55.4.268","volume":"55","author":"MA Brown","year":"1996","unstructured":"Brown MA, Pile KD, Kennedy LG et al (1996) HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 55:268\u201370","journal-title":"Ann Rheum Dis"},{"key":"6201_CR13","first-page":"518","volume":"30","author":"S Steer","year":"2003","unstructured":"Steer S, Jones H, Hibbert J et al (2003) Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn\u2019s disease. J Rheumatol 30:518\u201322","journal-title":"J Rheumatol"},{"key":"6201_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","volume":"118","author":"TR Orchard","year":"2000","unstructured":"Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Gaston JH, Jewell DP (2000) Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118:274\u20138","journal-title":"Gastroenterology"},{"key":"6201_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1046\/j.1365-2249.2001.01662.x","volume":"126","author":"T Orchard","year":"2001","unstructured":"Orchard T, Dhar A, Simmons J, Vaughan R, Welsh K, Jewell D (2001) MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy. Clin Exp Immunol 126:437\u201340","journal-title":"Clin Exp Immunol"},{"key":"6201_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms8146","volume":"6","author":"A Cortes","year":"2015","unstructured":"Cortes A, Pulit SL, Leo P et al (2015) Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat Commun 6:1\u20138","journal-title":"Nat Commun"},{"key":"6201_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/annrheumdis-2018-213779","volume":"78","author":"J Reveille","year":"2019","unstructured":"Reveille J, Zhou X, Lee M et al (2019) HLA class I and II alleles in susceptibility to ankylosing spondylitis. Ann Rheum Dis 78:66\u201373","journal-title":"Ann Rheum Dis"},{"key":"6201_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41584-019-0219-5","volume":"15","author":"R Busch","year":"2019","unstructured":"Busch R, Kollnberger S, Mellins ED (2019) HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications. Nat Rev Rheumatol 15:364\u201381","journal-title":"Nat Rev Rheumatol"},{"key":"6201_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus D, Jostins L, Spain S et al (2016) Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet 48:510\u2013518","journal-title":"Nat Genet"},{"issue":"1704\u201312","key":"6201_CR20","first-page":"e2","volume":"140","author":"JH Cho","year":"2011","unstructured":"Cho JH, Brant SR (2011) Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140(1704\u201312):e2","journal-title":"Gastroenterology"},{"key":"6201_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nrrheum.2010.216","volume":"7","author":"S Nanda","year":"2011","unstructured":"Nanda S (2011) Spondyloarthropathies: Novel genetic variants link ankylosing spondylitis and Crohn disease: evidence of a shared pathogenesis? Nat Rev Rheumatol 7:70","journal-title":"Nat Rev Rheumatol"},{"key":"6201_CR22","doi-asserted-by":"publisher","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","volume":"6","author":"P Danoy","year":"2010","unstructured":"Danoy P, Pryce K, Hadler J et al (2010) Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn\u2019s disease. PLoS Genet 6:e1001195","journal-title":"PLoS Genet"},{"key":"6201_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.733","volume":"43","author":"Y Momozawa","year":"2011","unstructured":"Momozawa Y, Mni M, Nakamura K et al (2011) Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 43:43\u20137","journal-title":"Nat Genet"},{"key":"6201_CR24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/ard.2007.080283","volume":"67","author":"B Rueda","year":"2008","unstructured":"Rueda B, Orozco G, Raya E et al (2008) The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 67:1451\u20134","journal-title":"Ann Rheum Dis"},{"key":"6201_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","volume":"110","author":"M De Vos","year":"1996","unstructured":"De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E (1996) Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 110:1696\u2013703","journal-title":"Gastroenterology"},{"key":"6201_CR26","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","volume":"180","author":"JD Taurog","year":"1994","unstructured":"Taurog JD, Richardson JA, Croft J et al (1994) The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180:2359\u201364","journal-title":"J Exp Med"},{"key":"6201_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJM197601152940301","volume":"294","author":"J Wands","year":"1976","unstructured":"Wands J, La Mont J, Mann E, Isselbacher K (1976) Arthritis associated with intestinal-bypass procedure for morbid obesity: complement activation and characterization of circulating cryoproteins. N Engl J Med 294:121\u20134","journal-title":"N Engl J Med"},{"key":"6201_CR28","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","volume":"166","author":"M Salmi","year":"2001","unstructured":"Salmi M, Jalkanen S (2001) Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 166:4650\u20137","journal-title":"J Immunol"},{"key":"6201_CR29","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1172\/JCI119389","volume":"99","author":"M Salmi","year":"1997","unstructured":"Salmi M, Rajala P, Jalkanen S (1997) Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Investig 99:2165\u201372","journal-title":"J Clin Investig"},{"key":"6201_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13075-018-1639-3","volume":"20","author":"EH Regner","year":"2018","unstructured":"Regner EH, Ohri N, Stahly A et al (2018) Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota. Arthritis Res Ther 20:149","journal-title":"Arthritis Res Ther"},{"key":"6201_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/ecco-jcc\/jjy125","volume":"13","author":"BG Feagan","year":"2018","unstructured":"Feagan BG, Sandborn WJ, Colombel J-F et al (2018) Incidence of arthritis\/arthralgia in inflammatory bowel disease with long-term vedolizumab treatment: post hoc analyses of the GEMINI Trials. J Crohn\u2019s Colitis 13:50\u20137","journal-title":"J Crohn's Colitis"},{"key":"6201_CR32","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1136\/annrheumdis-2016-209749","volume":"75","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Rizzo A, Guggino G, Bignone R, Galia M, Triolo G (2016) Clinical efficacy of \u03b14 integrin block with natalizumab in ankylosing spondylitis. Ann Rheum Dis 75:2053\u20134","journal-title":"Ann Rheum Dis"},{"key":"6201_CR33","doi-asserted-by":"crossref","unstructured":"Nakase H, Uchino M, Shinzaki S et al (2020) Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 56(6):489\u2013526","DOI":"10.1007\/s00535-021-01784-1"},{"key":"6201_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2019-215349","volume":"78","author":"Z Qaiyum","year":"2019","unstructured":"Qaiyum Z, Gracey E, Yao Y, Inman RD (2019) Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis. Ann Rheum Dis 78:1566\u201375","journal-title":"Ann Rheum Dis"},{"key":"6201_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/path.1044","volume":"196","author":"D Baeten","year":"2002","unstructured":"Baeten D, Demetter P, Cuvelier CA et al (2002) Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 196:343\u201350","journal-title":"J Pathol"},{"key":"6201_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02531-w","volume":"23","author":"AR Lefferts","year":"2021","unstructured":"Lefferts AR, Regner EH, Stahly A et al (2021) Circulating mature granzyme B+ T cells distinguish Crohn\u2019s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn\u2019s disease. Arthritis Res Ther 23:1\u201312","journal-title":"Arthritis Res Ther"},{"key":"6201_CR37","doi-asserted-by":"crossref","unstructured":"Lefferts A, Claypool D, Norman E, Kantheti U, Kuhn K (2021)\u00a0Cytokine competent gut-joint migratory T cells contribute to inflammation in the joint. Arthritis Rheumatol 73(suppl 10). https:\/\/acrabstracts.org\/abstract\/cytokine-competent-gut-joint-migratory-t-cells-contribute-to-inflammation-in-the-joint\/","DOI":"10.3389\/fimmu.2022.932393"},{"key":"6201_CR38","unstructured":"Viladomiu, Monica, et al (2017) IgA-coated E. coli enriched in Crohn\u2019s disease spondyloarthritis promote TH17-dependent inflammation. Sci Transl Med 9.376:eaaf9655"},{"key":"6201_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10108","volume":"22","author":"A Cardoneanu","year":"2021","unstructured":"Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E (2021) Characteristics of the intestinal microbiome in ankylosing spondylitis. Exp Ther Med 22:1\u201314","journal-title":"Exp Ther Med"},{"key":"6201_CR40","doi-asserted-by":"crossref","unstructured":"Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon\u00a0S et al. (2015)\u00a0Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol\u00a067(1):128\u2013139","DOI":"10.1002\/art.38892"},{"key":"6201_CR41","doi-asserted-by":"crossref","unstructured":"Soleimanifar N, Assadiasl S (2022) Spondyloarthropathies and gut microbiota. Ankylosing Spondylitis-Axial Spondyloarthritis. p. 139\u201355","DOI":"10.1007\/978-981-16-4733-8_6"},{"key":"6201_CR42","doi-asserted-by":"crossref","unstructured":"Chia AY, Ang GW, Chan AS, Chan W, Chong TK, Leung YY (2021)\u00a0Managing psoriatic arthritis with inflammatory bowel disease and\/or uveitis.\u00a0Front Med 8","DOI":"10.3389\/fmed.2021.737256"},{"key":"6201_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000500116","volume":"37","author":"M Cottone","year":"2019","unstructured":"Cottone M, Sapienza C, Macaluso FS, Cannizzaro M (2019) Psoriasis and inflammatory bowel disease. Dig Dis 37:451\u20137","journal-title":"Dig Dis"},{"key":"6201_CR44","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ecco-jcc\/jjaa260","volume":"15","author":"L Guillo","year":"2021","unstructured":"Guillo L, D\u2019Amico F, Danese S, Peyrin-Biroulet L (2021) Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review. J Crohn\u2019s Colitis 15:1236\u201343","journal-title":"J Crohn's Colitis"},{"key":"6201_CR45","doi-asserted-by":"crossref","unstructured":"Sands BE, Feagan BG, Sandborn WJ, Shipitofsky N, Marko M, Sheng S, ... Pan\u00e9s J (2022)\u00a0OP36 Efficacy and safety of combination induction therapy with guselkumab and golimumab in participants with moderately-to-severely active Ulcerative Colitis: Results through week 12 of a phase 2a randomized, double-blind, active-controlled, parallel-group, multicenter, proof-of-concept study. J Crohn's Colitis 16(Supplement 1):i042\u2013i043","DOI":"10.1093\/ecco-jcc\/jjab232.035"},{"key":"6201_CR46","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D Van der Heijde","year":"2019","unstructured":"Van der Heijde D, Song I, Pangan A et al (2019) Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet 394:2108\u20132117","journal-title":"Lancet"},{"key":"6201_CR47","unstructured":"Mease P, Helliwell P, Silwinska-Stanczyk P, Miakisz M, Ostor A, Peeva E, Vincent M, Sikirica V, Winnette R, Qiu R, Li G, Feng G, Beebe J, Martin D (2021)\u00a0Efficacy and safety of brepocitinib (tyrosine kinase 2\/janus kinase 1 inhibitor) for the treatment of active psoriatic arthritis: results from a phase 2b randomized controlled trial. Arthritis Rheumatol 73(Supplemental 10)"},{"key":"6201_CR48","doi-asserted-by":"crossref","unstructured":"Tanaka, Y, Luo Y, O\u2019Shea JJ, Nakayamada\u00a0S (2022)\u00a0Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach.\u00a0Nat Rev Rheumatol 1\u201313","DOI":"10.1038\/s41584-021-00726-8"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06201-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T21:45:41Z","timestamp":1675547141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6201"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06201-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"2 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}